Cargando…
_version_ 1784821585720377344
author Calabretta, Eleonora
Di Trani, Martina
Sollini, Martina
Ricci, Francesca
Corrado, Francesco
Cristaldi, Vanessa
Bonovas, Stefanos
Marino, Fabrizio
Mazza, Rita
Di Bergamo, Lodovico Terzi
Bruscaggin, Alessio
Pirosa, Maria Cristina
Bramanti, Stefania
Chiti, Arturo
Santoro, Armando
Rossi, Davide
Carlo-Stella, Carmelo
author_facet Calabretta, Eleonora
Di Trani, Martina
Sollini, Martina
Ricci, Francesca
Corrado, Francesco
Cristaldi, Vanessa
Bonovas, Stefanos
Marino, Fabrizio
Mazza, Rita
Di Bergamo, Lodovico Terzi
Bruscaggin, Alessio
Pirosa, Maria Cristina
Bramanti, Stefania
Chiti, Arturo
Santoro, Armando
Rossi, Davide
Carlo-Stella, Carmelo
author_sort Calabretta, Eleonora
collection PubMed
description
format Online
Article
Text
id pubmed-9621560
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-96215602022-11-01 P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma Calabretta, Eleonora Di Trani, Martina Sollini, Martina Ricci, Francesca Corrado, Francesco Cristaldi, Vanessa Bonovas, Stefanos Marino, Fabrizio Mazza, Rita Di Bergamo, Lodovico Terzi Bruscaggin, Alessio Pirosa, Maria Cristina Bramanti, Stefania Chiti, Arturo Santoro, Armando Rossi, Davide Carlo-Stella, Carmelo Hemasphere Relapsed/Refractory Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9621560/ http://dx.doi.org/10.1097/01.HS9.0000891000.99990.30 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Relapsed/Refractory
Calabretta, Eleonora
Di Trani, Martina
Sollini, Martina
Ricci, Francesca
Corrado, Francesco
Cristaldi, Vanessa
Bonovas, Stefanos
Marino, Fabrizio
Mazza, Rita
Di Bergamo, Lodovico Terzi
Bruscaggin, Alessio
Pirosa, Maria Cristina
Bramanti, Stefania
Chiti, Arturo
Santoro, Armando
Rossi, Davide
Carlo-Stella, Carmelo
P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
title P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
title_full P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
title_fullStr P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
title_full_unstemmed P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
title_short P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
title_sort p108: integrating baseline circulating tumor dna with interim pet improves outcome prediction in relapsed/refractory classical hodgkin lymphoma
topic Relapsed/Refractory
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621560/
http://dx.doi.org/10.1097/01.HS9.0000891000.99990.30
work_keys_str_mv AT calabrettaeleonora p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT ditranimartina p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT sollinimartina p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT riccifrancesca p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT corradofrancesco p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT cristaldivanessa p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT bonovasstefanos p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT marinofabrizio p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT mazzarita p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT dibergamolodovicoterzi p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT bruscagginalessio p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT pirosamariacristina p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT bramantistefania p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT chitiarturo p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT santoroarmando p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT rossidavide p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma
AT carlostellacarmelo p108integratingbaselinecirculatingtumordnawithinterimpetimprovesoutcomepredictioninrelapsedrefractoryclassicalhodgkinlymphoma